Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture

Alzheimer's disease (AD) is pathologically characterised by the age-dependent deposition of β-amyloid (Aβ) in senile plaques, intraneuronal accumulation of tau as neurofibrillary tangles, synaptic dysfunction and neuronal death. Neuroinflammation, typified by the accumulation of activated microglia and reactive astrocytes, is believed to modulate the development and/or progression of AD. We have used primary rat neuronal, astrocytic and mixed cortical cultures to investigate the contribution of astrocyte-mediated inflammatory responses during Aβ-induced neuronal loss. We report that the presence of small numbers of astrocytes exacerbate Aβ-induced neuronal death, caspase-3 activation and the production of caspase-3-cleaved tau. Furthermore, we show that astrocytes are essential for the Aβ-induced tau phosphorylation observed in primary neurons. The release of soluble inflammatory factor(s) from astrocytes accompanies these events, and inhibition of astrocyte activation with the anti-inflammatory agent, minocycline, reduces astrocytic inflammatory responses and the associated neuronal loss. Aβ-induced increases in caspase-3 activation and the production of caspase-3-truncated tau species in neurons were reduced when the astrocytic response was attenuated with minocycline. Taken together, these results show that astrocytes are important mediators of the neurotoxic events downstream of elevated Aβ in models of AD, and suggest that mechanisms underlying pro-inflammatory cytokine release might be an important target for therapy.

[1]  L. V. Van Eldik,et al.  Apolipoprotein E Attenuates β‐Amyloid‐Induced Astrocyte Activation , 1998 .

[2]  D. Jo,et al.  Proapoptotic Effects of Tau Cleavage Product Generated by Caspase-3 , 2001, Neurobiology of Disease.

[3]  W. Noble,et al.  Minocycline reduces the development of abnormal tau species in models of Alzheimer's disease , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  L. V. Van Eldik,et al.  Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches. , 2007, International review of neurobiology.

[5]  J. Cho,et al.  Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. , 2004, The Journal of biological chemistry.

[6]  Jialin C. Zheng,et al.  Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders , 2009, Journal of neurochemistry.

[7]  M. Hatten,et al.  Neuronal regulation of astroglial morphology and proliferation in vitro , 1985, The Journal of cell biology.

[8]  H. Arias,et al.  The role of inflammation in Alzheimer's disease. , 2005, The international journal of biochemistry & cell biology.

[9]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[10]  M. Lynch,et al.  The age‐related increase in IL‐1 type I receptor in rat hippocampus is coupled with an increase in caspase‐3 activation , 2002, The European journal of neuroscience.

[11]  P. Mcgeer,et al.  Neuroinflammation in Alzheimer's disease and mild cognitive impairment: a field in its infancy. , 2010, Journal of Alzheimer's disease : JAD.

[12]  C. Gottfried,et al.  Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology , 2000, FEBS letters.

[13]  R. Schliebs,et al.  Induction of cytokines in glial cells surrounding cortical β-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology , 2000, International Journal of Developmental Neuroscience.

[14]  W. Noble,et al.  Transgenic mouse models of tauopathy in drug discovery. , 2010, CNS & neurological disorders drug targets.

[15]  M. Mullan,et al.  p35/Cdk5 pathway mediates soluble amyloid‐β peptide‐induced tau phosphorylation in vitro , 2002, Journal of neuroscience research.

[16]  Kit-Yi Leung,et al.  Novel Phosphorylation Sites in Tau from Alzheimer Brain Support a Role for Casein Kinase 1 in Disease Pathogenesis* , 2007, Journal of Biological Chemistry.

[17]  J. Trojanowski,et al.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders , 2007, Nature Reviews Neuroscience.

[18]  B. Hyman,et al.  Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer’s disease , 2000, Journal of Neuroimmunology.

[19]  S. Hickman,et al.  Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice , 2008, The Journal of Neuroscience.

[20]  Tony Wyss-Coray,et al.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.

[21]  B. Sacchetti,et al.  Astrocyte modulation of in vitro β‐amyloid neurotoxicity , 2004, Glia.

[22]  R. Ransohoff,et al.  Regulation of Tau Pathology by the Microglial Fractalkine Receptor , 2010, Neuron.

[23]  M. Mattson,et al.  Amyloid β-peptide induces apoptosis-related events in synapses and dendrites , 1998, Brain Research.

[24]  D. Wallach,et al.  Cell death induction by TNF: a matter of self control. , 1997, Trends in biochemical sciences.

[25]  A. Nimmerjahn Astrocytes going live: advances and challenges , 2009, The Journal of physiology.

[26]  K. Pahan,et al.  Fibrillar Amyloid-β-Activated Human Astroglia Kill Primary Human Neurons via Neutral Sphingomyelinase: Implications for Alzheimer's Disease , 2010, The Journal of Neuroscience.

[27]  R. Swanson,et al.  Astrocytes protect neurons from nitric oxide toxicity by a glutathione‐dependent mechanism , 2001, Journal of neurochemistry.

[28]  R. Berry,et al.  Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Julien,et al.  Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease , 2006, Neuron.

[30]  M. Mattson,et al.  Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. , 1998, Brain research.

[31]  A. Verkhratsky,et al.  Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease , 2010, Glia.

[32]  P. Mcgeer,et al.  Inflammation in transgenic mouse models of neurodegenerative disorders. , 2010, Biochimica et biophysica acta.

[33]  C. Cotman,et al.  Inflammatory changes parallel the early stages of Alzheimer disease , 2007, Neurobiology of Aging.

[34]  W. Noble,et al.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. , 2009, Trends in molecular medicine.

[35]  J. Cho,et al.  Glycogen Synthase Kinase 3 (cid:1) Induces Caspase-cleaved Tau Aggregation in Situ * , 2022 .

[36]  Hymie Anisman,et al.  Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. , 2009, Journal of psychiatry & neuroscience : JPN.

[37]  Gilles Bonvento,et al.  Targeted Activation of Astrocytes: A Potential Neuroprotective Strategy , 2008, Molecular Neurobiology.

[38]  R. Rissman,et al.  Caspase-mediated degeneration in Alzheimer's disease. , 2004, The American journal of pathology.

[39]  J. Cooper,et al.  Anti-Inflammatory Impact of Minocycline in a Mouse Model of Tauopathy , 2010, Front. Psychiatry.

[40]  W. Noble,et al.  Kinase activities increase during the development of tauopathy in htau mice , 2007, Journal of neurochemistry.

[41]  C. Cotman,et al.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. , 2004, The Journal of clinical investigation.

[42]  L. V. Van Eldik,et al.  Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation. , 1998, Journal of neurochemistry.

[43]  L. Buée,et al.  P1–062: Alzheimer's disease–like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits , 2006, The American journal of pathology.

[44]  W. Bowers,et al.  Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD mice. , 2009, The American journal of pathology.

[45]  F. LaFerla,et al.  Reductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylation. , 2010, Journal of Alzheimer's disease : JAD.